Insiders · Profile

Foresite Capital Management V, LLC

10% owner at Latigo Biotherapeutics · 10% owner at ALUMIS. Filing since 1 Jul 2024. CIK 0001792206

Company
Date
Role
Action
Shares
Amount
Of holding
10 Aug 2026
10% owner
Bought
140,000
$2.52M
7.5%
1 Jul 2024
10% owner
Bought
2,500,000
$40.00M
81.0%
2 decisions on file.